Severe A(H1N1)-associated Pneumonia Sequential to Clamidophila pneumoniae Infection in Healthy Subject

In Vivo. 2011 Sep-Oct;25(5):825-8.

Abstract

Background: Pandemic influenza virus has been implicated in serious lower airways illness and death in subjects both with and without underlying medical conditions. Predictive factors for severe disease in healthy individuals have not been identified.

Case report: Severe A(H1N1)-associated pneumonia occurring in a healthy subject without underlying medical conditions sequential to a Clamidophila pneumoniae infection, is reported.

Conclusion: A potential synergistic mechanism by which other pathogens could interfere with the clinical course of A(H1N1) infection, is suggested.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antiviral Agents / therapeutic use
  • Azithromycin / therapeutic use
  • Cephalosporins / therapeutic use
  • Chlamydophila Infections / complications*
  • Chlamydophila Infections / diagnosis
  • Chlamydophila Infections / drug therapy
  • Chlamydophila pneumoniae*
  • Coinfection
  • Drug Therapy, Combination
  • Fluoroquinolones / therapeutic use
  • Humans
  • Influenza A Virus, H1N1 Subtype*
  • Influenza, Human / complications*
  • Influenza, Human / diagnosis
  • Influenza, Human / drug therapy
  • Male
  • Middle Aged
  • Ofloxacin / therapeutic use
  • Oseltamivir / therapeutic use
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / drug therapy

Substances

  • Anti-Bacterial Agents
  • Antiviral Agents
  • Cephalosporins
  • Fluoroquinolones
  • Oseltamivir
  • Azithromycin
  • Ofloxacin